Latest Developments

North America
CNBC Finance

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking the drugmaker's Foundayo, as the company tries to catch up to a lead in the space established by rival Novo. In an exclusive interview, he said the company's share of the oral market is growing week over week. "We're confident long term" about Lilly's place in the pill segment, Ricks said, especially as the company plans to launch Foundayo in more international markets in the coming months. Ricks spoke with CNBC in front of the roughly 240 acres of land that will eventually host Lilly's $6.5 billion manufacturing facility at Generation Park in Houston, Texas. The company on Monday broke ground on the upcoming site nearly a year after first announcing it, and said it expects the plant to be operational by 2030. The facility will most notably produce Lilly's closely watched GLP-1 pill for obesity, Foundayo, which entered the U.S. market in April. But the plant will be responsible for manufacturing the active ingredients for Lilly's other small-molecule medicines across several disease areas, such as cardiometabolic health, oncology, immunology and neuroscience. Ricks' comments and the groundbreaking came as Novo shares fell after the company's long-term strategy failed to assuage investor concerns about its ability to compete with Lilly in the obesity and diabetes market. While Novo beat Lilly to releasing a pill, Lilly said in August that it held about a 61% share in the overall market in the second quarter. The production site is part of a string of new investments Lilly has funneled into reshoring manufacturing across the U.S. over the last year. In February 2025, Lilly committed to spending an additional $27 billion to build four new facilities, including the Houston site, in part to build goodwill with President Donald Trump. But Lilly has also emphasized manufacturing capacity as a key competitive advantage against its main rival Novo alongside its drug portfolio. Since 2020, the company has committed more than $50 billion to expanding its manufacturing network, positioning itself to meet growing demand for obesity and diabetes treatments while supporting future product launches. Demand for Foundayo is rising in the U.S. The company said in August that the pill booked $98 million in sales for the second quarter — its first three-month period on the market. Medicare's new landmark coverage of obesity drugs, which began in July, is expected to open up more access to the pill and Lilly's blockbuster weight loss drug Zepbound. Get this delivered to your inbox, and more info about our products and services. Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
Europe
BBC Business

Sir David Beckham nets £38.5m after World Cup ad deals

Image source, Getty ImagesByArchie MitchellBusiness reporterPublished25 September 2026Sir David Beckham has netted a £38.5m payout from his sports, fashion, and media business after the 2026 Men's Football World Cup helped it bring in record profits. The former England star's DRJB Holdings, which includes the Beckham brand, reported an almost £50m profit in 2025, a 46% jump compared to a year earlier. Sales rose from £72.2m to £84m. The rise was driven by a slew of advertising partnerships struck in the runup to the tournament, including with Bank of America, McDonald's, Verizon, and PepsiCo Lay's. Sir David, Britain's first billionaire sportsman, was commonly seen in adverts during the summer's World Cup. In the US, it was difficult for fans to watch a game without coming across Beckham in adverts for Stella Artois, Home Depot and Lay's crisps - known as Walkers in the UK. Sir David also launched menswear collections for Hugo Boss last year, as well as a pair of Adidas Predator football boots and an eyewear range with Italian glasses maker Safilo. Revenues at DRJB, of which Beckham owns almost half, were boosted by growth in Beckham's health supplements business too. DRJB paid its shareholders £38.9m, followed by a special £46.6m payment after the end of the financial year. Sir David's share of those dividends would have been around £38.5m due to how much of the company he owns. The remainder of DRJB is owned by New York-based Authentic Brands Group, which also owns Reebok, as well as the rights to other celebrity brands such as comedian and actor Kevin Hart. Authentic's entertainment chief executive Corey Salter said the performance showed Sir David's name is "one of the most powerful global brands in sport, lifestyle, entertainment and much more". "It's been an outstanding year, from new partnerships to important philanthropic campaigns and overall brand growth," he said.

Sir David Beckham nets £38.5m after World Cup ad deals
North America
CNBC Finance

Auto industry urges Trump to bar Chinese automakers in U.S. ahead of Xi visit

The American automotive industry wants President Donald Trump to maintain policies that make it difficult for Chinese automakers to operate in the U.S. — or even ban them altogether. In a letter to Trump dated Thursday and viewed by CNBC, groups representing major facets of the U.S. automotive industry — from franchised dealers and suppliers to domestic and foreign automakers — urged the president to "maintain policies that keep the door firmly shut to Chinese automakers seeking to sell, import or manufacture vehicles inside the U.S." "The automotive sector is foundational to our advanced manufacturing and defense base, with the capacity and workforce to respond during a national emergency. Once that base is hollowed out, it can't be rebuilt overnight," the letter reads. The letter comes ahead of Trump's expected visit next week with Chinese President Xi Jinping in Washington, as well as Trump last week saying he would permit Chinese automakers to move manufacturing to the U.S. "If China wanted to come in and open a plant to build their cars here, I'd be OK with it," Trump said Sept. 11 on Fox News' "The Ingraham Angle." The letter argues that allowing Chinese automakers to manufacture in the U.S. would "undermine fair competition and jeopardize the progress" the administration has made in preventing "Chinese dominance in key industries." Chinese automakers are heavily subsidized by their government and are rapidly expanding outside of China to other countries. The letter is the latest in a string of messages from the automotive industry to the Trump administration, but this time represented a more unified coalition. It was signed by leaders of six trade associations that represent every major automaker operating in the U.S., including Tesla and foreign automakers, as well as the nation's roughly 17,000 franchised dealers. Get this delivered to your inbox, and more info about our products and services. Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Auto industry urges Trump to bar Chinese automakers in U.S. ahead of Xi visit
Europe
The Guardian

CNN and MS Now journalists denied access to White House state dinner despite court ruling

Journalists for CNN and MS Now were denied access to the White House state dinner in honor of Xi Jinping, China’s president, on Thursday evening, hours after a federal judge ruled the Trump administration must allow them in after imposing a ban last week. “About an hour before Xi’s arrival was scheduled, the White House said CNN could cover the event, but only with a photojournalist and audio technician, notably excluding the network’s editorial team consisting of a reporter and producer,” CNN reported. MS Now, another outlet banned from the White House by Trump last week for what he calls overly negative coverage of his presidency, also said its White House reporter, Laura Barrón-López, was prevented from covering Xi’s arrival for the state dinner despite applying for credentials to cover the event. When Barrón-López asked a White House staffer why she was denied access, the staffer said she should “talk to Steven”, apparently meaning White House communications director Steven Cheung, MS Now reported. Xi’s arrival for the dinner, with his wife, Peng Liyuan, was streamed live on YouTube by the White House, but none of the major US networks provided live broadcast video of the event in solidarity with CNN, a member of the broadcast pool. Earlier on Thursday, journalists for CNN, MS Now and Politico, which was also part of the ban issued last week, were finally granted access to the White House after days of being barred from the building. Earlier attempts by the journalists to enter the building had been unsuccessful, and lawyers representing the three organizations had told a judge that the White House has already “repeatedly violated” his overnight order requiring the Trump administration to return the press badges of journalists from the three news organizations. Timothy Kelly, the US district judge who appeared skeptical of arguments from lawyers representing the White House during a hearing on Wednesday, issued an early morning order forcing the administration to return access for a 14-day period. But journalists from the three affected networks reported being barred from the building, with some having their badges taken for the first time. “This morning journalists from each of CNN, MS Now, and Politico attempted to enter the White House and were turned away, and Secret Service agents confiscated the hard pass of journalists whose hard passes had not previously been confiscated,” lawyers for the three news organizations wrote in a brief requesting a video or telephone conference “as soon as possible this morning”. In a legal filing on Thursday afternoon, Micah Stopperich, the White House director of press operations, said in a sworn statement that the operations team was notified at 7.10am to restore access, and that it began reinstating badges at 7.25am. She said that US Secret Service indicated that badges were re-activated as of 9.07am, and that confiscated badges were dropped off at the entry to the building just before 10am. “United States Secret Service has represented that press passes that were turned on were available for pick up at the press gate as soon as they were delivered,” she said. The badges were revoked on Saturday, after the president abruptly ordered the three outlets to be banned over “their constant ‘reporting’ FAKE NEWS”. The outlets swiftly sued over the move, which sparked widespread criticism from other news organizations and press freedom advocates.

CNN and MS Now journalists denied access to White House state dinner despite court ruling
Europe
BBC Business

Special agents' blood and urine test results stolen in FBI hack

Image source, Anadolu via Getty ImagesByJoe Tidy World Service Cyber Correspondent Published25 September 2026Cyber-criminals who hacked the FBI say they have extremely sensitive medical data for thousands of its special agents. BBC News has seen samples of the stolen "fitness-for-work" medical examinations, which contain information such as blood and urine test results, and doctors' notes mentioning conditions such as a "shellfish and banana allergy". The records include agents' full names and addresses, as well as references to medical concerns including 'blood in the urine' and 'high cholesterol'. Experts say the hack - which the FBI is investigating - could leave agents vulnerable to scams, blackmail and targeted attacks, as well as help criminals impersonate law enforcement officers. "The list maps thousands of agents against their medical and fitness records," said Etay Maor, vice-president of threat intelligence at Cato Networks. "Passwords can be reset if stolen, but medical records cannot, so once this data is out, it stays compromised for good. That permanence, applied across an entire workforce, is what makes this leak so serious." The FBI has not responded to requests for comment. However, on Wednesday it acknowledged the breach and said it was "aggressively investigating" how it happened. The cyber-criminal group ShinyHunters claims it breached FBI systems on Monday, and later posted details of the attack on its darknet site. The group also shared samples of the alleged stolen data with reporters, along with an extortion demand. Unusually, the hackers are not demanding money. Instead, they are seeking a retraction of an FBI advisory published in May, which they claim "offended" them. The samples shared with journalists appear genuine and include names, addresses, phone numbers, badge numbers, job titles and information about spouses. The records appear to relate to thousands of agents, including senior officials such as deputy directors.

Special agents' blood and urine test results stolen in FBI hack
Europe
BBC Business

'We're all broke': Would you chase a friend for £5?

You pick up the bill for dinner, pay for the taxi home or grab a friend's coffee with the promise they'll pay you back later, but days go by and the money never arrives. For some, $5 (£3.70) is worth a reminder, while for others, asking a friend to repay anything under $20 (£15) feels more awkward than simply taking the hit. Henry Payne says he's "sent a request for $8.50, but I wouldn't go lower than $8". The 21-year-old New Yorker adds that he will chase someone once but "two requests is insane". He does admit that he's sometimes the person on the other side of the transaction and can be forgetful himself. "For everyone that I haven't sent back money to, I just forgot, feel free to double request me." Kaz Jahanbini, 19, says needing to ask to be paid back in the first place can be frustrating. "If someone bought me something, I'm immediately paying them back. So then I'm thinking for them, what's the delay?" His rule for navigating friendship and finances is to "keep your wallet close but your friends closer". His friend Nouria agrees and says as a student "every extra dollar counts" but she would usually only ask for money back from a friend if it was more than $10. A recent study, external found that 76% of Gen Z who have fronted money for a group expense, like a trip or event, say they were not fully repaid, and 55% say it created tension or negatively affected a relationship. For British student Betsie Brooke-Taylor, 19, the threshold to ask for money back is a fiver as she says "every little helps".

'We're all broke': Would you chase a friend for £5?
North America
CNBC Finance

Nissan eyes increasing U.S. production as new Rogue hybrid launches

Nissan Motor is looking to increase its U.S. production as it launches the 2027 Rogue crossover, including with a new hybrid model that the company views as a crucial offering for American consumers. "We're now maxing out the production capacity in the U.S.," Christian Meunier, chairman of Nissan Americas, told CNBC. "The next step is going to be three shifts, and I'm pretty optimistic that with the launch of the new Rogue that is happening in the next couple months, we'll be able to do that pretty quickly with the launch of the hybrid." The Japanese automaker currently produces the Rogue alongside other Nissan and Infiniti crossovers at a 6 million-square-foot assembly plant on two production shifts in Smyrna, Tennessee. It also has another large manufacturing plant producing the Nissan Altima sedan and Frontier midsize pickup truck in Canton, Mississippi. Additional production at assembly plants typically means hundreds, if not thousands, of new jobs. Nissan's moves come as the Trump administration has been focused on increasing employment and domestic production in the U.S. auto industry. U.S. manufacturing of the hybrid is expected to start next year after the spring production launch of the 2027 Rogue with a traditional gas engine at the Tennessee plant. In the meantime, Meunier said Nissan plans to import the vehicles from Japan as a way to get them to market more quickly to lift sales and help with an ongoing global turnaround plan for the company. Meunier said if Nissan can add a third shift to each of its assembly plants, it would boost the automaker's U.S. production to roughly 1 million units annually, up from nearly 487,000 in 2025. Nissan has a target to produce 80% of the vehicles it sells in the U.S. domestically by 2030, but the company has no plans for a new plant as of now. "I think we're very well equipped to succeed without major investment and a new factory and everything else. Maybe after 2030," he said. "Over the next four or five years, we'll see." Nissan on Monday officially revealed the 2027 Rogue with its new "e-Power" technology for the U.S., which is the first hybrid of its kind for the American market. It uses the engine as a generator to power the vehicle's electric motors that then propel the vehicle. It operates like emerging extended-range electric vehicles, or EREVs, but has a smaller battery and doesn't require a plug. It also does not use the engine to power the wheels, just electric motors. Meunier said the Rogue hybrid and resurrecting the Xterra off-road SUV were his top vehicle priorities when he rejoined Nissan in January 2025 after four and a half years with Jeep. That included pulling ahead the Rogue hybrid twice for the U.S.

Nissan eyes increasing U.S. production as new Rogue hybrid launches
Europe
The Guardian

Revealed: the undisclosed safety data emerging as weedkiller maker faces Parkinson’s lawsuits in US

Clues to how and why the US remains one of the world’s last large markets for widespread paraquat use are coming to light through troves of internal Syngenta records recently revealed through litigation. Composite: The Guardian/Getty Images/SyngentaView image in fullscreenClues to how and why the US remains one of the world’s last large markets for widespread paraquat use are coming to light through troves of internal Syngenta records recently revealed through litigation. Composite: The Guardian/Getty Images/SyngentaPesticidesRevealed: the undisclosed safety data emerging as weedkiller maker faces Parkinson’s lawsuits in USSyngenta denies keeping relevant data from the EPA as paraquat stays in the US market despite global bans Sweden started ringing the alarm bell more than 20 years ago, calling for a ban on the weedkilling chemical paraquat in 2004. One by one, dozens of other countries did the same as evidence of paraquat risks to human health mounted. Even the Chinese government, which owns the longtime paraquat maker Syngenta, halted domestic use of the pesticide a decade ago after conducting its own studies on paraquat safety and finding troubling results. In the US, two states – Vermont and California – have recently also banned paraquat, citing risks that include an association between paraquat and Parkinson’s disease shown in years of scientific research. And California regulators announced in August that paraquat makers voluntarily agreed to stop selling the chemical after the state identified health concerns in connection with its use in new research. Several federal lawmakers have pushed for a nationwide ban. Yet amid the global cloud of concern, the US Environmental Protection Agency (EPA) continues to greenlight paraquat use on millions of acres, and has downplayed scientific findings linking paraquat to Parkinson’s, an incurable brain disease. The agency said in June it would hold a round table over the summer to re-examine the “safety challenges” associated with paraquat. But no such event has yet been held or scheduled. Now, clues to how and why the US remains one of the world’s last large markets for widespread paraquat use are coming to light through troves of internal Syngenta records recently revealed through litigation. The records show that as paraquat markets around the world started crumbling over concerns for public health, Syngenta, a Swiss-headquartered multinational, fought to keep a tight hold on the US market, where use of paraquat nearly tripled between 2000 and 2018, a time period when dozens of other countries were banning paraquat. Internal corporate records, depositions and other records show that before and during this time frame, Syngenta did not share certain internal data and other information with the EPA regarding paraquat health effects and risks despite federal legal requirements for companies to report information about “unreasonable adverse effects” of their products. Among the data not shared by Syngenta were analyses of how quickly the chemical could permeate untreated clothing; how fast it could absorb into an applicator’s skin and bloodstream. The company also did not share some information about how mixing paraquat with surfactants increases the chemical’s absorption. Surfactants are additives commonly used by farm workers to help herbicides overcome the waxy, water-repellent surface of their leaves. Certain information demonstrating dire risks to the brain from exposure was also not shared with the EPA. In contrast, the company focused on developing and promoting science showing paraquat safety that it could share with regulators, including one published in 2016 that company insiders noted would be “invaluable in supporting our work”. In 2022 and 2023, the New Lede and the Guardian obtained and revealed a set of internal corporate records showing that Syngenta and its predecessor corporate entities used an array of secret tactics for decades to downplay and discredit science linking what the company called its “blockbuster” weedkiller to Parkinson’s and other chronic health issues. The newly released files, totaling roughly 3,700 pages, provide more insights into the company’s handling of paraquat concerns, as well as multiple examples of information Syngenta did not share with the EPA. The records were submitted to a Pennsylvania state court where cases have been filed by people with Parkinson’s alleging that they developed the disease from exposure to paraquat products. Earlier this month the underlying lawsuit in which the documents were filed was dismissed by the judge due to the plaintiff not having sufficient proof of exposure to paraquat; however, there are thousands more active cases pending around the country. In the face of the ongoing litigation, which has already cost the company at least $187m in a 2021 settlement and an undisclosed further amount for additional settlements since then, Syngenta announced earlier this year it would stop all global production of paraquat.

Revealed: the undisclosed safety data emerging as weedkiller maker faces Parkinson’s lawsuits in US
North America
Yahoo Finance

US Stock Futures Rise as Investors Monitor Middle East Oil Supplies and AI Policy Developments: Dow Jones, S&P, Nasdaq, Wall Street

US stock futures advanced on Monday as investors assessed developments in the Middle East, declining oil prices and artificial intelligence policy discussions between Washington and Beijing. At 06:58 GMT, Dow Jones Industrial Average futures were up 239 points, or 0.5%, while S&P 500 futures gained 39 points, also rising 0.5%. Nasdaq 100 futures advanced 218 points, or 0.7%. Wall Street ended Friday’s session with mixed results. The S&P 500 and Nasdaq Composite closed higher, while the Dow Jones Industrial Average declined slightly. US Treasury yields increased across maturities as market expectations for another Federal Reserve interest rate increase before the end of 2026 remained broadly unchanged. Analysts at Vital Knowledge attributed much of Friday’s equity market gains to companies supplying infrastructure and components for artificial intelligence, including semiconductor manufacturers. The analysts also noted that the Bank of Japan’s latest interest rate increase was less restrictive than some investors had anticipated, with two policymakers voting to leave rates unchanged. The yen weakened following the decision, prompting concerns among the analysts about the possibility of Japanese authorities selling US Treasury securities to support the currency. Investors continued to monitor the conflict in Yemen after reports of intensified fighting between Iran-backed Houthi forces and Saudi-aligned groups over the weekend. The New York Times, citing a Saudi army officer, reported clashes in mountainous areas of southwestern Yemen on Sunday. The fighting comes amid competition for positions near the Bab el-Mandeb Strait, a shipping passage connecting the Gulf of Aden with the Red Sea. Saudi Arabia has increasingly relied on this route to export crude oil following disruptions to shipping through the Strait of Hormuz. According to The New York Times, the Houthis also said they had launched missiles and drones towards Riyadh and targeted Saudi oil facilities in response to Saudi air strikes inside Yemen.

US Stock Futures Rise as Investors Monitor Middle East Oil Supplies and AI Policy Developments: Dow Jones, S&P, Nasdaq, Wall Street